• PRM57 Developing BASDAI and BASFI Predictive Equations From Clinical Trial Data of Golimumab for Severe, Active Ankylosing Spondylitis in Adults

    Nov 1, 2012, 00:00

  • PSY32 Measuring the Level Impact of Neuropathic Pain in the EU

    Nov 1, 2012, 00:00

  • PDB27 The Relationship Between the Presence of Metabolic Complications and Cost Components of Type 2 Diabetes Mellitus Patients in Turkey

    Nov 1, 2012, 00:00

  • PGI14 Knowledge, Attitude and Practices Towards Hepatitis-B Among General Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PRM172 The Value of Personalized Medicine- It is More About Unveiling the Performance of the Companion Diagnostic

    Nov 1, 2012, 00:00

  • PRM32 Reliability and Validity of an Instrument Used in a Tobacco Cessation Intervention Study Among Patients With Diabetes

    Nov 1, 2012, 00:00

  • PND9 Burden of Multiple Sclerosis (MS) in China

    Nov 1, 2012, 00:00

  • PMH26 Cost-Effectiveness of Atypical Versus Typical Antipsychotics in Patients With Schizophrenia in Russia

    Nov 1, 2012, 00:00

  • PCN25 Utility of Advanced Non-Small Cell Lung Cancer Patients in Thailand- Preliminary Study

    Nov 1, 2012, 00:00

  • PCV28 2-Year Incidence of Stroke and Hemorrhages Hospitalizations and Costs Within Atrial Fibrillation Patients in France

    Nov 1, 2012, 00:00

  • PIH21 Health Economic Evidence in Support of a Low-Dose Contraceptive Levonorgestrel Intrauterine System (LNG-IUS 12)

    Nov 1, 2012, 00:00

  • PRM81 Methods of Obtaining Evidence From Published Survival Data for Use in Decision Analytic Models

    Nov 1, 2012, 00:00

  • PCV75 Complementing Data for Rare Diseases - Comparing Data From National Registries to a European Chart Abstraction Study for Patients With Chronic Thromboembolic Pulmonary Hypertension

    Nov 1, 2012, 00:00

  • PCN40 Year to Year Budget Impact Analysis of Biological Therapies for First-Line Treatment of Metastatic Colorectal Cancer in Spain

    Nov 1, 2012, 00:00

  • PHP186 Trends in the Use of Health Economic Data to Inform Global Market Access Decisions- Preliminary Results from an Online Survey

    Nov 1, 2012, 00:00

  • PND45 Differential Outcomes in Patients With Alzheimer'S Disease (AD) Treated With Donepezil 23

    Nov 1, 2012, 00:00

  • PMD33 The Impact of Three Different Imaging Strategies on Surgery Planning for Patients With Colorectal Cancer Liver Metastases

    Nov 1, 2012, 00:00

  • PMD1 Economic Value of Screening for Early Parkinson's Disease in a European Setting

    Nov 1, 2012, 00:00

  • PDB33 Physician'S and Patient'S Perceptions and Beliefs Regarding Insulin Initiation and Use in Patients With Type 2 Diabetes (T2DM) in China

    Nov 1, 2012, 00:00

  • PHP42 Health Economics in the Czech Republic and Insurance Coverage Decision Making in 2008-2009- A Retrospective Analysis

    Nov 1, 2012, 00:00

  • PMD92 Inhaler Use in Five European Countries- Analysis of Sales Data From Q4 2005 to Q4 2011

    Nov 1, 2012, 00:00

  • PSS16 Cost-Effectiveness of Tacrolimus Ointment in Children With Moderate and Severe Atopic Dermatitis- Twice-Daily Maintenance Treatment Versus Standard Twice-Daily Reactive Treatment of Exacerbations From the Perspective of the Spanish Na ...

    Nov 1, 2012, 00:00

  • PRM113 Development of a Generic Spanish Version of the Modified Myelofibrosis Symptom Assessment Form (MFSAF) Diary

    Nov 1, 2012, 00:00

  • PMD89 Diagnostic Accuracy of Early Biomarkers for Acute Coronary Syndrome (ACS)

    Nov 1, 2012, 00:00

  • PHS37 Cost Minimization Analysis in the Treatment of Community Acquired Pneumonia in Ukraine

    Nov 1, 2012, 00:00

  • PHS50 Health Care Resource Use and Cost in Alzheimer's Disease in Three European Countries – Baseline Findings of the GERAS Study

    Nov 1, 2012, 00:00

  • PRM107 Nonprobability Versus Probability-Based Patient Sampling- Understanding Response Variation and Implications

    Nov 1, 2012, 00:00

  • PGI34 A Patient-Reported Outcome Model for Crohn's Disease

    Nov 1, 2012, 00:00

  • EX4 Recent Trends in Community Pharmacy Payment of National Health Insurance in South Korea

    Nov 1, 2012, 00:00

  • PIN67 Cost Minimization Comparison of a Vaccination With Campaign Program for Corporations Using PCV13 Vesus Free PCV10 With Paid Campaign

    Nov 1, 2012, 00:00

  • PCV6 Comparative Effectiveness of Different Drug-Eluting Coronary Stents - A Systematic Review of Taiwan Studies

    Nov 1, 2012, 00:00

  • PHP29 Innovative Technologies - Factors Influencing Financing Decisions in Italian Hospitals

    Nov 1, 2012, 00:00

  • PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic Review

    Nov 1, 2012, 00:00

  • PCN116 Mapping FACT-P to EQ-5D in a Large Cross-Sectional Study of Metastatic Castrate-Resistant Prostate Cancer Patients

    Nov 1, 2012, 00:00

  • PCN41 Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients Undergoing Surgery in British Hospitals

    Nov 1, 2012, 00:00

  • PUK1 A Swedish Prospective Observational Study to Evaluate the Impact in Quality of Life Among Previously Untreated Patients Receiving Their First Prescription of Solifenacin. (SPOQ-Study)

    Nov 1, 2012, 00:00

  • PSY9 Medical Cost of Organ Damage Due to Systemic Lupus Erythematosus

    Nov 1, 2012, 00:00

  • PRM148 Sample Size and Power Considerations in Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PHS18 Economic Burden of Atopic Dermatitis from a United States Payer Perspective

    Nov 1, 2012, 00:00

  • PRS13 Discriminating the Price of a Product Based on the Target Patient Segment by Launching Different Delivery Mechanisms- A Comparison of China, India and Korea

    Nov 1, 2012, 00:00

  • PND10 Faster Cognitive Decline is Associated With Decreasing Survival in Patients With Alzheimer'S Disease

    Nov 1, 2012, 00:00

  • PCV61 Pharmacoeconomic Evaluation of Olmesartan, Losartan and Valsartan in Treatment of Essential Arterial Hypertension

    Nov 1, 2012, 00:00

  • PHP3 Integration of Evidence on Patient Preferences in Health Care Decision Making- Current State of Play

    Nov 1, 2012, 00:00

  • PDB34 Improvements in Quality of Life Associated With Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients in China- Results from the A1Chieve Observational Study

    Nov 1, 2012, 00:00

  • PCV108 Analysis of Outpatient Utilization and Costs of Antithrombotic Drugs in Poland – Implications for Pharmaceutical Pricing and Reimbursement Policy

    Nov 1, 2012, 00:00

  • PHP45 Impact of Generics Policy on the Generic Penetration

    Nov 1, 2012, 00:00

  • PSY41 Symptoms and Impacts Associated With Anaemia of Chronic Kidney Disease (CKD)

    Nov 1, 2012, 00:00

  • PCV2 Comparative Efficacy and Safety Analysis of Atrial Fibrillaion Patients Treated with Dabigatran in RE-LY Study (CHADS 2 Score of 3 or Greater ) Versus Rivaroxaban in ROCKET-AF

    Nov 1, 2012, 00:00

  • PCN24 Treatment and Response Patterns in Chronic Myeloid Leukemia- Evidence from a Retrospective Study in Canada, Australia, and South Korea

    Nov 1, 2012, 00:00

  • PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PRM42 Managing a Systematic Literature Review Project

    Nov 1, 2012, 00:00

  • PHP91 Is There an Overuse of Computed Tomography (CT) Scanning of Patients in United States Hospitals? A Review of the Evidence

    Nov 1, 2012, 00:00

  • PHP39 Prescription Filling on Outpatient Health Care Departments- An Indonesia Family Life Survey (IFLS) Year 2007 – 2008 Based Study

    Nov 1, 2012, 00:00

  • PSY18 Clinical Outcomes, Resource Utilization and Treatment Cost of Myelodysplastic Syndromes and Acute Myeloide Leukemia in a Real World Setting- Single-Center Experience

    Nov 1, 2012, 00:00

  • PMH13 Dementia and Alzheimer'S Disease in China- Characterization and Caregiver Burden

    Nov 1, 2012, 00:00

  • PHS95 The Suicidality in Thai Population- A National Survey

    Nov 1, 2012, 00:00

  • PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

    Nov 1, 2012, 00:00

  • PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis Media

    Nov 1, 2012, 00:00

  • PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in Austria

    Nov 1, 2012, 00:00

  • PHP70 A Systematic Review of Hospital-at-Home Care- Cost Savings are Overestimated

    Nov 1, 2012, 00:00

  • PMH10 Cost-Effectiveness of Antidepressant Based on Discrete Event Simulation Modeling in Treatment of Major Depressive Episodes- A Comparison of Agomelatine Versus Escitalopram-Venlafaxine

    Nov 1, 2012, 00:00

  • PIH7 Net Tax Revenue with a National Based Rotavirus Vaccination Program in Turkey

    Nov 1, 2012, 00:00

  • PHS87 Cost of Diabetes in Insulin-Treated Patients in Bulgaria

    Nov 1, 2012, 00:00

  • PMH44 Validity and Responsiveness of the EQ-5D and the Kidscreen-10 in Children With ADHD

    Nov 1, 2012, 00:00

  • PND35 Buccolam® (Licensed Oromucosal Midazolam) Versus Rectal Diazepam for Acute Epileptic Seizures- Italian Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PGI3 Determination of Efficacy, Adverse Drug Reactions and Cost Effectiveness of Three Triple Drug Regimens for the Treatment of H. Pylori Infected Acid Peptic Disease Patients

    Nov 1, 2012, 00:00

  • PMH27 Cost-Effectiveness Analysis of Depression in Italy

    Nov 1, 2012, 00:00

  • PIN15 Economic Evaluation of Vaccination in Southeast Asian Countries- A Systematic Review

    Nov 1, 2012, 00:00

  • PHP98 The Industry Survey Results Regarding Korea PE Guideline Revision

    Nov 1, 2012, 00:00

  • PDB6 Predictors of Reaching HbA1C Goal in T2Dm Patients Using Dipeptidyl Peptidase-4 Inhibitors (DPP4Is) Combination Therapy- A Subgroup Analysis

    Nov 1, 2012, 00:00

  • PHS93 HbA1c Test Utilization Among Hospitalized Patients With Hyperglycemia

    Nov 1, 2012, 00:00

  • PHS83 Potential Time Savings With Rituximab Subcutaneous (SC) Injection Versus Rituximab Intravenous (IV) Infusion- Results from Interviews at 13 European Sites As Part of a Time and Motion Study (TM)

    Nov 1, 2012, 00:00

  • PMH55 Payer Value in Alternative Treatment Formulations- Access to New Medicines in Schizophrenia

    Nov 1, 2012, 00:00

  • PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy with Gonadotropin-Releasing Hormone Analogues- Leuprorelin, Goserelin, Triptorelin

    Nov 1, 2012, 00:00

  • PRM37 Development and Use of a Health-Related Quality of Life Tool to Help Veterinarians and Pet Owners Assess Aging Changes in Pet Dogs

    Nov 1, 2012, 00:00

  • PMS11 Budget Impact Analysis in Spanish Patients With Dupuytren's Contracture- Fasciectomy Versus Collagenase Clostridium Histolyticum

    Nov 1, 2012, 00:00

  • PRM96 Reliability of a Patient-Reported Adverse Drug Event Questionnaire

    Nov 1, 2012, 00:00

  • PHP21 Does National Essential Medicine System Improve Rational Drug Use in Primary Health Care Facilities? An Empirical Study in Rural China

    Nov 1, 2012, 00:00

  • PGI24 Cost-Effectiveness Analysis of 48-Week Peginterferon Alpha-2a Under RGT Strategy Versus 3 Years Entecavir for the Treatment of HBeAg-Positive Chronic Hepatitis B in China

    Nov 1, 2012, 00:00

  • PHP14 The Implementation of Essential Medicine Policy in China- Pros and Cons

    Nov 1, 2012, 00:00

  • PCN5 Cabazitaxel Plus Corticosteroids in Comparison to Corticosteroids Alone for the Treatment of Metastatic Hormone Refractory / Castration-Resistant Prostate Cancer (mHRPC)

    Nov 1, 2012, 00:00

  • PMD73 Quality of Life and Resource Use After Transcatheter Aortic Valve Implantation. Preliminary Results of an Observational Multicentre Study

    Nov 1, 2012, 00:00

  • PHP48 Irrational Use of Antibiotics in Balochistan. A Warning for Health Care System

    Nov 1, 2012, 00:00

  • PCV40 Pharmacotherapy Cost of Patients With Hypertension in Bulgaria

    Nov 1, 2012, 00:00

  • PRM31 Chinese Valuation of EQ-5D Health States With the Time Trade-Off Method

    Nov 1, 2012, 00:00

  • PHS47 Cost-Utility Analysis of Rotigotine in Restless Legs Syndrome from the NHS Scotland Perspective

    Nov 1, 2012, 00:00

  • PMS16 Economic Evidence of Biologics in Rheumatoid Arthritis- A Systematic Review for Supporting Informed Decision of BNHI

    Nov 1, 2012, 00:00

  • PND11 Estimating Survival-Benefit of New Therapeutic Interventions in Cystic Fibrosis Patients in Germany, France, UK and Ireland

    Nov 1, 2012, 00:00

  • PCN8 The Association Between Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk in Taiwan- A Population-Based Cohort Study

    Nov 1, 2012, 00:00

  • PIH26 Social Impact of Adalimumab in the Italian Perspective

    Nov 1, 2012, 00:00

  • PRM10 Use of VA Databases for Retrospective Studies in Ulcerative Colitis Outcomes Research

    Nov 1, 2012, 00:00

  • PMD78 The Switch Study- The Impact of Continuous Glucose Monitoring on Quality of Life and Treatment Satisfaction

    Nov 1, 2012, 00:00

  • PHP132 Time to Market Access for Innovative Drugs in the UK, France, and Belgium

    Nov 1, 2012, 00:00

  • PDB70 Characteristics of Long-Acting Somatostatin (SSA) Use in Acromegaly in the Netherlands

    Nov 1, 2012, 00:00

  • PRM137 Reminders Help Improving Completion Rate of Home-Administered Lifestyle Questionnaires

    Nov 1, 2012, 00:00

  • PCN103 How Much Price Component is Accounted for in State Drugs Purchase Decisions in Ukrainian Oncology?

    Nov 1, 2012, 00:00

  • PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain

    Nov 1, 2012, 00:00

  • PCV42 Model Sensitivity Analysis of Venous Thromboembolism Prevention After Total Hip Replacement

    Nov 1, 2012, 00:00

  • PRM115 Modelling the Relationship Between Disease Severity and Utility in Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PHP74 Cost-of-Illness of Patient-Reported Adverse Drug Events – a Population-Based Survey

    Nov 1, 2012, 00:00

  • PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PMS54 A Retrospective Cohort Study of Persistence Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PHP61 To Evaluate the Effectiveness and Cost of Pharmaceutical Care Volunteer Set Up by Tainan City Government Involved in the Hospital Attached Home Care Patients

    Nov 1, 2012, 00:00

  • PHP53 Comparative Evaluation of Drug Information Sources Used by Doctors

    Nov 1, 2012, 00:00

  • PMD3 Pre-Screening Tools- A Neglected Approach to Diagnose and Cut Cost Associated With Osteoporosis

    Nov 1, 2012, 00:00

  • PRM35 Relative Efficiency of the SF-8, SF-12, and SF-36 in the General Population

    Nov 1, 2012, 00:00

  • PCV111 Unmet Therapeutic Needs for Patients With Dyslipidemia According to ATP III Guidelines

    Nov 1, 2012, 00:00

  • PSS7 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study)- 6-Month Findings

    Nov 1, 2012, 00:00

  • PMD47 Economic Evaluation of Reduced Futile 1st Line Therapy in Metastatic Renal Cell Carcinoma Patients Using Early Angiogenesis-Specific Imaging

    Nov 1, 2012, 00:00

  • PMD39 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed Countries

    Nov 1, 2012, 00:00

  • PUK12 Cost-Effectiveness of Immunosuppressive Regimens in Renal Transplant Recipients in Germany- A Model Update

    Nov 1, 2012, 00:00

  • PDB74 Effective Health Care Budget Planning for Innovative Drugs in Diabetes Treatment in Turkey; From the Perspective of the Social Security Institution (SSI)

    Nov 1, 2012, 00:00

  • PCN7 A Systematic Review of the Heterogeneity of Treatment Effect in Ovarian Cancer (OC)—Are There Implications for Outcomes Research?

    Nov 1, 2012, 00:00

  • PHS38 Cost-Effectiveness Analysis of a Helpline for Suicide Prevention

    Nov 1, 2012, 00:00

  • PMH34 Persistence in Use of Antidepressants in Pregnant Women Enrolled in Medicaid in the United States

    Nov 1, 2012, 00:00

  • PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada

    Nov 1, 2012, 00:00

  • PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation

    Nov 1, 2012, 00:00

  • RU3 Some Issues With the Icer in Technology Assessments of Screening Interventions for Rare Conditions

    Nov 1, 2012, 00:00

  • RU4 Universal Versus Selective Screening for Down'S Syndrome- An Economic Evaluation of Resource Use and Costs by Screening Policy

    Nov 1, 2012, 00:00

  • PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder- Patient Characteristics and 1-Year Costs

    Nov 1, 2012, 00:00

  • PHP108 Pattern of Antibiotics Usage in Malaysian Hajj Pilgrim

    Nov 1, 2012, 00:00

  • PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PRM16 Access to Cost Data Capture Using Public Database, Website and Literature in Germany, France, Spain and USA

    Nov 1, 2012, 00:00

  • PCN140 The Evaluation of Health Care Resource Utilization in Patients With Metastatic Castration Resistant Prostate Cancer- Results of a Multinational Observational Study

    Nov 1, 2012, 00:00

  • PHP7 How Do Reimbursement Systems Encourage or Inhibit Adoption of Innovative Medical Devices in an Ambulatory Setting?

    Nov 1, 2012, 00:00

  • PRM2 Assessing Relative Clinical Value Within Three Metastatic Diseases

    Nov 1, 2012, 00:00

  • PSY17 Cost-Utility Analysis of Immune Tolerance Induction (ITI) Therapy Versus On-Demand Treatment With Recombinant FVII (rFVIIa) for Hemophilia A With High Titer Inhibitors in Iran

    Nov 1, 2012, 00:00

  • PHP116 Orphan Drug Pricing and Access – Current Situation and Future Trends in EU

    Nov 1, 2012, 00:00

  • PCV14 Colesevelam for the Treatment of Hyperlipidemia- A Retrospective ‘Real-World' Analysis From an Integrated Health System

    Nov 1, 2012, 00:00

  • PIH37 Trends of Quality of Life in South Korean Adults During 2007-2010

    Nov 1, 2012, 00:00

  • PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany

    Nov 1, 2012, 00:00

  • PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures

    Nov 1, 2012, 00:00

  • PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a Problem

    Nov 1, 2012, 00:00

  • PRM119 Mapping Between Composite Measures in Psoriatic Arthritis and the SF-6D- Analysis From the Grace Dataset

    Nov 1, 2012, 00:00

  • PHP170 The Swiss Health Technology Assessment (HTA) Consensus- Guiding Principles

    Nov 1, 2012, 00:00

  • PMS24 A Systematic Review of Existing Utility Weight Estimates in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • HC3 The Process of Updating the Items of National Health Insurance Benefits Schedule in Taiwan- is It Fair and Legitimate?

    Nov 1, 2012, 00:00

  • PHS75 Analysis of Costs and Reimbursement of Hospital Treatment of Venous Thromboembolism in Poland

    Nov 1, 2012, 00:00

  • PRM128 Development of a Translation Evidence Tracking Tool to Comply With the FDA Review Requirements for the Translation of PRO Instruments

    Nov 1, 2012, 00:00

  • PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in Kazakhstan

    Nov 1, 2012, 00:00

  • PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PHP48 Health Financing for Prisoners with HIV- Lesson Learned from Indonesia

    Nov 1, 2012, 00:00

  • PCV20 Possible Budget Impact of Internal Reference Pricing for Statins in Turkey

    Nov 1, 2012, 00:00

  • PCN35 Survival Estimates of Six Major Advanced and Metastatic Solid Tumors in Europe- A Cancer Registry and Literature Review

    Nov 1, 2012, 00:00

  • PRM156 How to Increase Patient Retention Rate During Their Participation in Longitudinal Studies

    Nov 1, 2012, 00:00

  • PND4 Capsaicin 8% Patch Monotherapy for Treatment of Post-Herpetic Neuralgia- Integrated Analysis of Phase III Studies

    Nov 1, 2012, 00:00

  • PHP131 Ensuring That Phase III Programs are Designed to Meet the Evolving HTA Requirements Across the EU5

    Nov 1, 2012, 00:00

  • PHP94 Effectiveness and Cost-Benefit of a Bupivacaine Physician Educational Programme in Minimizing the Spinal Anesthesia Failure Rate- Report from a Tertiary-Care Hospital in Central Taiwan

    Nov 1, 2012, 00:00

  • PMD82 Implantable Cardioverter Defibrillator in Italy From 2000 to 2008- A Population-Based Analysis Using Health Administrative Databases

    Nov 1, 2012, 00:00

  • PSS4 The Cost-Effectiveness of Travoprost Preserved With Polyquad® in Newly Treated Open-Angle Glaucoma Patients in 7 Asian Countries

    Nov 1, 2012, 00:00

  • PMH22 Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

    Nov 1, 2012, 00:00

  • PIN1 Effect of Antitubercolosis Treatment on Lever Enzymes

    Nov 1, 2012, 00:00

  • PHP30 The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in Taiwan

    Nov 1, 2012, 00:00

  • PMD48 Structured SMBG in Iranian People With Type 2 Diabetes- A Cost Consequence Analysis

    Nov 1, 2012, 00:00

  • PIH47 Analysis of the Formulary Provision of Children in Ukraine

    Nov 1, 2012, 00:00

  • PCV7 A Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients with Non-Valvular Atrial Fibrillation (NVAF)

    Nov 1, 2012, 00:00

  • PHP32 Analyzing the Utilities of Fluoroquinolones at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PIN18 Rates of Influenza Complications by High Risk Group

    Nov 1, 2012, 00:00

  • PMS22 Indirect Costs Associated With Rheumatoid Arthritis in Turkey

    Nov 1, 2012, 00:00

  • PCV98 Health Related Quality of Life and Age in Hypertensive Patients- Self-Perception and Evaluation by Professionals. The Equality Study

    Nov 1, 2012, 00:00

  • PRS4 Comparative Efficacy of Aclidinium Bromide 400 Mcg Bid Versus Tiotropium 18 Mcg and 5 Mcg QD as Maintenance Bronchodilator Treatment to Relieve Symptoms in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)- A Network Met ...

    Nov 1, 2012, 00:00

  • PSY10 An Indirect Comparison of Icatibant and Four Other Therapies for the Symptomatic Treatment of Acute Attacks of Hereditary Angioedema Types I and II

    Nov 1, 2012, 00:00

  • PCV3 Prevalence, Associated Comorbidities and Treatment Patterns Among Chronic Kidney Disease Patients- An Analysis Using UK GPRD Data

    Nov 1, 2012, 00:00

  • PIN20 Budget Impact of Backbone Choice in Italian Treatment- Naïve, HIV-Infected Patients

    Nov 1, 2012, 00:00

  • PGI27 Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults With Irritable Bowel Syndrome With Constipation

    Nov 1, 2012, 00:00

  • PCN29 HRQOL During Adjuvant Chemotherapy With Capecitabine in Patients After Surgery for Colon Cancer- Additional Study of JFMC37-0801

    Nov 1, 2012, 00:00

  • PHS61 Patient Involvement in Treatment Decisions and Its Perceived Impact on Patient Outcomes in Systemic Lupus Erythematosus (SLE)- A Comparison of Physician and Patient Perspectives

    Nov 1, 2012, 00:00

  • CL4 Marginal Structural Models Used in Estimating Cost-Effectiveness of Time-Varying Drug Therapy Using Adimistrative Databases. The Case of Statin in Secondary Prevention

    Nov 1, 2012, 00:00

  • PSY11 The Effect of Serum Albumin Level With Kabiven for Nutrition Support in a Regional Hospital

    Nov 1, 2012, 00:00

  • PSU1 3-Year Real-World Outcomes With the Swedish Adjustable Gastric Bandtm in France

    Nov 1, 2012, 00:00

  • PSU31 The Association Between Degenerative Disk Disease and Outcomes Among Patients Undergoing Lumbar Fusion Surgery

    Nov 1, 2012, 00:00

  • PRM14 Proposed Checking Points to Evaluate Report of Multiple Treatment Comparison (MTC) Analysis in the Submission of New Drug Reimbursement and Pricing Application to the National Health Insurance in Taiwan

    Nov 1, 2012, 00:00

  • PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention

    Nov 1, 2012, 00:00

  • PRM45 Utility Estimation for Visual Acuity Health States- An Original and Pragmatic Approach to Transpose Published Evidence Into a More Flexible Estimation

    Nov 1, 2012, 00:00

  • PCN27 Disclosing Complementary and Alternative Medicines (CAM) Use to the Health Care Providers-A Descriptive Study

    Nov 1, 2012, 00:00

  • PCV35 Costs of Treating Cardiovascular Diseases in Germany- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PCV84 Misdiagnosis and Mistreatment of ACE-Inhibitor Induced Cough Decreases Therapy Compliance

    Nov 1, 2012, 00:00

  • PHP89 Perception Analysis of Pharmaceutical Care Practices Among General Physicians from Part of South India

    Nov 1, 2012, 00:00

  • PRM54 Correlating Cost Effectiveness Output With Patient Level Data Input via the IMS Core Diabetes Model (CDM)

    Nov 1, 2012, 00:00

  • PGI26 Within-Trial Analysis to Estimate the Economically Justifiable Price of Linaclotide in the Treatment of Irritable Bowel Syndrome With Constipation in the UK

    Nov 1, 2012, 00:00

  • PMS32 Cost-Efectiveness Analysis of Anti-Osteoporotic Therapy Among Korean Women With Postmenopausal Osteoporosis

    Nov 1, 2012, 00:00

  • PMD31 Impact of Using a Vessel Sealer System and the Harmonic Scalpel in Hospital Outcomes and Cost of Thyroidectomy Procedures

    Nov 1, 2012, 00:00

  • PMH30 Cost-Minimization-Analysis of Paliperidon Palmitate in the Treatment of Schizophrenia in Austria

    Nov 1, 2012, 00:00

  • PND5 Budget Impact of Oral Prolonged-Release Fampridine for Management of Walking Disability Associated With Multiple Sclerosis in Taiwan

    Nov 1, 2012, 00:00

  • PRM22 The Headroom Method of Early Economic Evaluation of Medical Devices- A Useful Tool for Device Developers?

    Nov 1, 2012, 00:00

  • PRM101 A Think Aloud Study Comparing the Validity and Acceptability of Discrete Choice and Best Worst Scaling Methods

    Nov 1, 2012, 00:00

  • PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C

    Nov 1, 2012, 00:00

  • PIH3 Demographic and Clinical Characteristics of Menopausal Women in the University of Michigan Women's Registry Database

    Nov 1, 2012, 00:00

  • PMH42 Assessing Impacts of Major Depressive Disorder (MDD) on Cognitive Function

    Nov 1, 2012, 00:00

  • PHP28 Reasons for Project Discontinuation in the Pharmaceutical Industry

    Nov 1, 2012, 00:00

  • PMS2 Improvements in Physical Function and Disability in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial

    Nov 1, 2012, 00:00

  • PR2 Guiding Principles for Providing Effective Access to Medicines in Emerging Markets

    Nov 1, 2012, 00:00

  • PHP72 Making Money Work for Improvement of Patient Care- Success and Shortcomings of Pay-for-Performance Program in Taiwan

    Nov 1, 2012, 00:00

  • PCN81 Cost Effectiveness of Pazopanib in Soft Tissue Sarcoma

    Nov 1, 2012, 00:00

  • PMD58 Cost-Effectiveness Analysis of Leprosy Case Detection Methods in Northern Nigeria

    Nov 1, 2012, 00:00

  • PHS45 Cost Effectiveness Analysis of a Specialist Service and Adrenaline Injectors in Anaphylaxis

    Nov 1, 2012, 00:00

  • PCN23 Cost-Effectiveness Analysis of Gefitinib for Lung Cancer- A Population Based Study

    Nov 1, 2012, 00:00

  • PRM142 Use of Body Surface Area As a Determinant of Dose in Cancer Studies

    Nov 1, 2012, 00:00

  • PRM170 Optimizing Public Health Decision Over Time- A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

    Nov 1, 2012, 00:00

  • PHP28 Systematic Review on Factors Affecting Pharmaceutical Expenditures

    Nov 1, 2012, 00:00

  • PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PCV88 Venous Thromboembolism- A Systematic Literature Review to Identify Multi-Attribute Utility Values for Use in Economic Models

    Nov 1, 2012, 00:00

  • PSU16 High Cost Patients for Cardiac Surgery and Hospital Quality in Turkey

    Nov 1, 2012, 00:00

  • PCN126 Can a Population-Based Patient Registry Improve the Feasibility of Outcomes Research in Multiple Myeloma?

    Nov 1, 2012, 00:00

  • PND17 Comparing Cost of Therapeutic Plasma Exchange and Intravenous Immunoglobulin Infusion in Treating Guillain-BarrÉ Syndrome

    Nov 1, 2012, 00:00

  • PHP80 Effectiveness of Multidisciplinary Perspective Intervention with Community Involvement in Decreasing Antibiotic Sales in Village Groceries in Thailand

    Nov 1, 2012, 00:00

  • PHP41 Risk Management in Iranian Pharmaceutical Companies to Ensure Accessibility and Quality of Medicines

    Nov 1, 2012, 00:00

  • PSU32 A Comparison of Resource Utilization and Medical Charges Among Lumbar Interbody Fusion Surgical Patients With and Without Revision

    Nov 1, 2012, 00:00

  • PND28 Health Care Costs of Multiple Sclerosis in Germany

    Nov 1, 2012, 00:00

  • PDB18 Population Attributable Risk of Microvascular Events Associated With HbA1C, Blood Pressure or Weight in Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PDB29 Glycemic Control and Diabetes-Related Health Care Costs in Type 2 Diabetes. A Retrospective Analysis Based on Administrative and Clinical Data

    Nov 1, 2012, 00:00

  • PMD40 Burden of SSI in Gastrointestinal, Cardiac and Orthopaedic Surgeries in Korea

    Nov 1, 2012, 00:00

  • PCN136 Expenditures on Orphan Drugs in Canada, Europe (EU5 + Belgium, Sweden and the Netherlands) and Australia in 2009

    Nov 1, 2012, 00:00

  • PHP143 Exploratory Test of Stakeholder Theory in the Implementation Process of It-Innovations in Hospital Care

    Nov 1, 2012, 00:00

  • DB3 Indirect Treatment Comparison (ITC) or Cost-Effectiveness Analysis (CEA)- a Study

    Nov 1, 2012, 00:00

  • PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia- An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients

    Nov 1, 2012, 00:00

  • DB1 Epidemiology, Treatment and Economic Burden of Type 2 Diabetes Mellitus With Nephropathy Complications in China

    Nov 1, 2012, 00:00

  • PDB16 Prospective and Retrospective Safety Review of Pioglitazone in a Medical Center

    Nov 1, 2012, 00:00

  • PUK14 Cost-Effectiveness Analysis of Mirabegron Versus Tolterodine Extended Release in the Treatment of Patients With Overactive Bladder in the United States

    Nov 1, 2012, 00:00

  • PMD62 Cost-Effectiveness in Diagnostic Tests- Comparison of the IBD Pre-Endoscopic Screening F-Calprotectin Test Versus Serologic Markers in Selected European Markets

    Nov 1, 2012, 00:00

  • PRM49 EQ-5D Versus Disease-Specific HR-QoL Instruments – No Contest?

    Nov 1, 2012, 00:00

  • PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of Chemotherapy

    Nov 1, 2012, 00:00

  • PHS85 The Cost of Public Cancer Prevention in Alberta

    Nov 1, 2012, 00:00

  • PCV39 Cost Assessment of Drugs for Venous Thromboembolism Prevention After Hip or Knee Replacement in Mexican Population

    Nov 1, 2012, 00:00

  • PSU7 Seasonal Periodicity of Secondary Hip Replacement After Femoral Neck Fractures With Reduction Internal Screw Fixation Aged Over 60

    Nov 1, 2012, 00:00

  • PHS41 Cost Effectiveness Analysis of Two HIV Counseling and Testing Strategies in Kayunga District (Uganda)

    Nov 1, 2012, 00:00

  • PRM64 Bayesian MTC Models to Combine Evidence From Different Trial Designs

    Nov 1, 2012, 00:00

  • PDB14 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus in Asia- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHP88 Workplace-Based Smoking Cessation Programmes – Identifying the Gaps Between Evidence and Practice

    Nov 1, 2012, 00:00

  • PCN159 Melody Brazil - Treatment Patterns in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PSY8 Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response (MMR) in Newly Diagnosed Chronic Myeloid Leukemia Patients in Greece

    Nov 1, 2012, 00:00

  • PSS8 Health Burden of Vision Problems in Asia- A Study of Malays and Indians in Singapore

    Nov 1, 2012, 00:00

  • PCN155 Is Sale of Tobacco and Smoking Prevalence Predictors of Future Lung Cancer Incidence?

    Nov 1, 2012, 00:00

  • PMD29 Comparing the Economic Impact of Prosthesis Choice in Unicompartmental Knee Arthroplasty Procedures- Development of an Economic Model

    Nov 1, 2012, 00:00

  • PIH24 Economic Evaluation of Ulipristal Acetate Tablets for the Treatment of Patients with Moderate and Severe Symptoms of Uterine Fibroids

    Nov 1, 2012, 00:00

  • PMS63 Assessment of the Osteoporosis Self-Efficacy Scale in Relation to Osteoprotective Behaviors among Type 2 Diabetics Patients in North Malaysia

    Nov 1, 2012, 00:00

  • PHP103 Challenges and Future Prospects of Nursing Workforce in Greece

    Nov 1, 2012, 00:00

  • ME1 Comparison of the Measurement Properties Between the 5-Level EuroQoL Group's 5-Dimension (EQ-5D-5L) Questionnaire and the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PMH25 An Assessement of the Cost-Effectiveness of Escitalopram Versus Multiple Comparators as First Line Antidepressant in Patients With Major Depressive Disorder (MDD) in Belgium

    Nov 1, 2012, 00:00

  • PSU5 Bariatric Surgery From the Perspective of Brazilian National Health System (SUS)

    Nov 1, 2012, 00:00

  • PR1 Does Medication Adherence Correlate With Health-Related Quality of Life? Findings From a Descriptive Analysis

    Nov 1, 2012, 00:00

  • PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic Medication

    Nov 1, 2012, 00:00

  • PSU8 Budget Impact Analysis of Anti-Bacterial Suture Use in Appendectomy Procedures in Spain

    Nov 1, 2012, 00:00

  • PRS6 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients- A Study From Emergency Room of a Chest Hospital in Delhi, India

    Nov 1, 2012, 00:00

  • PDB3 How Different Were They? A Treatment Pattern Analysis of United States Patients With Type 2 Diabetes Mellitus (T2DM) Initiating Injectable Therapy

    Nov 1, 2012, 00:00

  • PHP147 Early Access Programmes (EAPs)- Review of the European System

    Nov 1, 2012, 00:00

  • PHP15 The Impact of Orphan Drug Incentives on Innovation and Pricing in Niche Therapeutic Markets- A Systematic Review of the Literature

    Nov 1, 2012, 00:00

  • PMH10 Patient Persistence With Buprenorhine/Naloxone Film and Tablet Formulations in the Treatment of Opioid Dependence in the United States- Results From a Large Privately Insured Retrospective Database

    Nov 1, 2012, 00:00

  • PCV24 Economic Analysis of Bemiparin and Enoxaparin Used for Thrombosis and Embolism Prevention in Orthopedic Patients in Russia

    Nov 1, 2012, 00:00

  • A Comparison of Preferences of Targeted Therapy for Metastatic Renal Cell Carcinoma between the Patient Group and Health Care Professional Group in South Korea

    Sep 1, 2012, 00:00

  • State-Transition Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

    Sep 1, 2012, 00:00

  • Quality-of-Life Impact of Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer Patients

    Sep 1, 2012, 00:00

  • The Utility Assessment Method Order Influences Measurement of Parents' Risk Attitude

    Sep 1, 2012, 00:00

  • Conceptualizing a Model- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2

    Sep 1, 2012, 00:00

  • Instructions for Authors

    Sep 1, 2012, 00:00

  • Orthopaedic Trauma Care in Haiti- A Cost-Effectiveness Analysis of an Innovative Surgical Residency Program

    Sep 1, 2012, 00:00

  • An Evaluation Framework for Funding Drugs for Rare Diseases

    Sep 1, 2012, 00:00

  • Dementia Care in the General Practice Setting- A Cluster Randomized Trial on the Effectiveness and Cost Impact of Three Management Strategies

    Sep 1, 2012, 00:00

  • Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families- Observations from the Dosing Observational Study in Hemophilia

    Sep 1, 2012, 00:00

  • Development of a Decision-Analytic Model for the Application of STR-Based Provenance Testing of Transrectal Prostate Biopsy Specimens

    Sep 1, 2012, 00:00

  • Relative Effectiveness Assessment of Pharmaceuticals- Similarities and Differences in 29 Jurisdictions

    Sep 1, 2012, 00:00

  • Letter from the Editors

    Sep 1, 2012, 00:00

  • Evaluating New Health Technologies and Disease Burden in Developed Countries

    Sep 1, 2012, 00:00

  • The Inclusion of Informal Care in Applied Economic Evaluation- A Review

    Sep 1, 2012, 00:00

  • Model Parameter Estimation and Uncertainty- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    Sep 1, 2012, 00:00

  • Copyright/Subscription

    Sep 1, 2012, 00:00

  • Model Transparency and Validation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

    Sep 1, 2012, 00:00

  • Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response

    Sep 1, 2012, 00:00

  • Creating Models That Meet Decision Makers' Needs- A US Payer Perspective

    Sep 1, 2012, 00:00

  • Costs of Adverse Drug Events in German Hospitals—A Microcosting Study

    Sep 1, 2012, 00:00

  • Innovation and the Burden of Disease—Reply to Letter to the Editor by Catalá-López et al

    Sep 1, 2012, 00:00

  • Editorial Board

    Sep 1, 2012, 00:00

  • FDA Actions Against Health Economic Promotions, 2002–2011

    Sep 1, 2012, 00:00

  • Matching-Adjusted Indirect Comparisons- A New Tool for Timely Comparative Effectiveness Research

    Sep 1, 2012, 00:00

  • Table of Contents

    Sep 1, 2012, 00:00

  • The View of a Model user on the ISPOR-SMDM Modeling Good Research Task Force Report

    Sep 1, 2012, 00:00

  • Modeling using Discrete Event Simulation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

    Sep 1, 2012, 00:00

  • Dynamic Transmission Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

    Sep 1, 2012, 00:00

  • Modeling Good Research Practices—Overview- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

    Sep 1, 2012, 00:00

  • Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada

    Sep 1, 2012, 00:00

  • Multicriteria Decision Analysis for Including Health Interventions in the Universal Health Coverage Benefit Package in Thailand

    Sep 1, 2012, 00:00

  • Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies

    Sep 1, 2012, 00:00

  • Instructions for Authors

    Jul 1, 2012, 00:00

  • Economic Evaluation and the Jordan Rational Drug List- An Exploratory Study of National-Level Priority Setting

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas

    Jul 1, 2012, 00:00

  • Validation of the UFS-QOL-Hysterectomy Questionnaire- Modifying an Existing Measure for Comparative Effectiveness Research

    Jul 1, 2012, 00:00

  • How Do Insured Perceive Their Financial Security in the Event of Illness?—A Panel Data Analysis for Germany

    Jul 1, 2012, 00:00

  • Modeling the Risks and Benefits of Depression Treatment for Children and Young Adults

    Jul 1, 2012, 00:00

  • Erratum

    Jul 1, 2012, 00:00

  • Willingness to Pay for Prostate Cancer Treatment among Patients and Their Family Members at 1 Year After Diagnosis

    Jul 1, 2012, 00:00

  • The Maximum Willingness to Pay for Smoking Cessation Method among Adult Smokers in Mexico

    Jul 1, 2012, 00:00

  • Financial Risk-Sharing in Updating the National List of Health Services in Israel- Stakeholders' Perceived Interests

    Jul 1, 2012, 00:00

  • Valuing the Extended Role of Prescribing Pharmacist in General Practice- Results from a Discrete Choice Experiment

    Jul 1, 2012, 00:00

  • Table of Contents

    Jul 1, 2012, 00:00

  • Editorial Board

    Jul 1, 2012, 00:00

  • Combining Individual-Level Discrete Choice Experiment Estimates and Costs to Inform Health Care Management Decisions about Customized Care- The Case of Follow-Up Strategies after Breast Cancer Treatment

    Jul 1, 2012, 00:00

  • Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries- How Much Could Be Saved?

    Jul 1, 2012, 00:00

  • Inverse Probability Weighted Least Squares Regression in the Analysis of Time-Censored Cost Data- An Evaluation of the Approach Using SEER-Medicare

    Jul 1, 2012, 00:00

  • Development of a Database of Instruments for Resource-Use Measurement- Purpose, Feasibility, and Design

    Jul 1, 2012, 00:00

  • Improving the Measurement of QALYs in Dementia- Some Important Considerations

    Jul 1, 2012, 00:00

  • Cost-Effectiveness Analysis of the Bivalent Compared with the Quadrivalent Human Papillomavirus Vaccines in Taiwan

    Jul 1, 2012, 00:00

  • Does Responsibility Affect the Public's Valuation of Health Care Interventions? A Relative Valuation Approach to Health Care Safety

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ5D Mapping Algorithm—Reply to Letter to the Editor by David Cella, Irina Proskorovsky, and Feng Pan

    Jul 1, 2012, 00:00

  • Interim Scoring for the EQ-5D-5L- Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

    Jul 1, 2012, 00:00

  • Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales- A Cost-Utility Analysis

    Jul 1, 2012, 00:00

  • The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland

    Jul 1, 2012, 00:00

  • Time Trade-Off and Ranking Exercises Are Sensitive to Different Dimensions of EQ-5D Health States

    Jul 1, 2012, 00:00

  • Deriving Input Parameters for Cost-Effectiveness Modeling- Taxonomy of Data Types and Approaches to Their Statistical Synthesis

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States

    Jul 1, 2012, 00:00

  • Whose Values in Health? An Empirical Comparison of the Application of Adolescent and Adult Values for the CHU-9D and AQOL-6D in the Australian Adolescent General Population

    Jul 1, 2012, 00:00

  • Heterogeneous Effects of Health Insurance on Out-of-Pocket Expenditure on Medicines in Mexico

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ-5D Questionnaire Mapping Algorithm

    Jul 1, 2012, 00:00

  • Copyright/Subscription

    Jul 1, 2012, 00:00

  • Response to Comments on Mulhern et al., “Improving the Measurement of QALYs in Dementia- Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis”

    Jul 1, 2012, 00:00

  • PHP15 What Price do we Pay for Repurposing Medicines for Rare Diseases?

    Jun 1, 2012, 00:00

  • PDB92 The Evolution of Oral Anti-Diabetes Medication Use in Taiwan (1999-2009)

    Jun 1, 2012, 00:00

  • PCN73 Economic Evaluation of Antithrombotic Therapies in Patients With Cancer in Mexico

    Jun 1, 2012, 00:00

  • PHP35 Determinants of Participation in Mammography Screening in Taiwan

    Jun 1, 2012, 00:00

  • PMS63 Treatment with Infliximab Improves the Quality of Life of Rheumatoid Arthritis Patients in China

    Jun 1, 2012, 00:00

  • PMD62 A Simulated Control Group Comparative Approach to Using Phase I Trial Data to Assess the Outcomes of a Novel Treatment for Acute Kidney Failure

    Jun 1, 2012, 00:00

  • PMH66 Growth in Antidepressant Use in 10 Countries in the Last Decade

    Jun 1, 2012, 00:00

  • PIN49 Patient Reported Quality of Life Following Antiretroviral Therapy in a Nigerian Hospital

    Jun 1, 2012, 00:00

  • CE1 Cost Effectiveness Trends of High Budget Impact Drugs (2006-2012)

    Jun 1, 2012, 00:00

  • PMD23 Health Care Utilization and Costs in Patients Experiencing Bone Fracture Nonunion

    Jun 1, 2012, 00:00

  • PDB31 Targeted Cost Saving Strategies in Diabetes Prevention Using Risk Stratification

    Jun 1, 2012, 00:00

  • PDB107 Patient Characteristics and Outcomes Among Individuals With Type 2 Diabetes- A Comparison Based Upon Adherence

    Jun 1, 2012, 00:00

  • PSY60 Pain Management- Observation and Side Effects

    Jun 1, 2012, 00:00

  • PDB17 Using a Novel, Graphical Method to Analyze Complex Treatment Patterns For Patients With Acromegaly

    Jun 1, 2012, 00:00

  • PRS38 A Survey of Asthma Management Programs in Managed Care Organizations

    Jun 1, 2012, 00:00

  • PRM27 A Method of Projecting Future Co-Morbidity Prevalence and Health Service Demand in the United Kingdom Population Using the Health Improvement Network (THIN)

    Jun 1, 2012, 00:00

  • PCV85 Effect of Secondary Preventive Measures on the Health Related Quality of Life of Myocardial Infarction Patients

    Jun 1, 2012, 00:00

  • PHP108 Analyzing the New Era of National Coverage Determinations (NCD'S) by the Centers for Medicare Medcaid Services (CMS) Post its Sipuleucel-T Decision

    Jun 1, 2012, 00:00

  • PSY4 Prevalence of Autoimmune Diseases and Other Comorbidities in Patients With Psoriasis in the United States

    Jun 1, 2012, 00:00

  • PRM10 The Behavioral Economics of the Minimally Important Difference

    Jun 1, 2012, 00:00

  • PMD52 Inpatient Reimbursement Landscape for Medical Device and Diagnostics in Developed Markets

    Jun 1, 2012, 00:00

  • PUK30 Once Monthly Erythropoiesis Stimulating Agent (ESA) Dosing May Reduce ESA Utilization Compared to Thrice-Weekly ESA Dosing

    Jun 1, 2012, 00:00

  • PSU29 The Importance of Medical Appointments After Roux-en-Y Gastric Bypass in Morbid Obese Patients- Association Between Adherence to Medical Follow-Up Visits and the Bariatric Analysis and Reporting Outcome System (BAROS) Score Based on a ...

    Jun 1, 2012, 00:00

  • PCN129 Association Between BMI and Personal Health and Screening History, Preventive Care, and Wellness Behaviors Among Participants in a Mobile Mammography Program

    Jun 1, 2012, 00:00

  • PDB52 Cost-Effectiveness of Renal Screening Strategies and Treatment Options for Patients With Type 1 Diabetes in the United Kingdom

    Jun 1, 2012, 00:00

  • PMH15 Trends in Prevalence of ADHD Drug Treatment in the Netherlands from 2000 Until 2010

    Jun 1, 2012, 00:00

  • PCV90 The Quality of Anticoagulation Therapy in Patients with Atrial Fibrillation

    Jun 1, 2012, 00:00

  • PSY37 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 600/800mg Daily as Therapy for Imatinib Failing Chronic Myeloid Leukemia (CML)

    Jun 1, 2012, 00:00

  • PHP55 Evidence Based Advertisement- Where is the Pharmacoeconomic and Humanistic Outcomes Research Evidence?

    Jun 1, 2012, 00:00

  • PCN7 Life Expectancies and Prognostic Factors of Survival in Patients With Different Types of Cancer Under Prolonged Mechanical Ventilation- A Nation-Wide Analysis of 5,138 Cases During 1998-2007

    Jun 1, 2012, 00:00

  • PSU26 Cost-Utility Analysis of Bariatric Surgery for the Treatment of Obese Patients in South Korea

    Jun 1, 2012, 00:00

  • PMS66 Satisfaction with and Preference for Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients Switched from Adalimumab or Etanercept

    Jun 1, 2012, 00:00

  • PMS78 Analyzing the Difference in Health Care Costs of Rheumatoid Arthritis Patients Switching or Dose Escalating Anti-TNF Biologics Using Combined Propensity Score Matching and Multivariate Regression Model

    Jun 1, 2012, 00:00

  • PSS9 Economic Burden of Wet Age-Related Macular Degeneration (WAMD) in Urban China

    Jun 1, 2012, 00:00

  • PHP61 The Financial Impacts of Pharmacist Intervention in Inpatient Department of a Local Hospital in Taiwan

    Jun 1, 2012, 00:00

  • PDB94 The Trend of Influenza and Pneumococcal Vaccination Among Adults With Diabetes in the United States, 2006-2010

    Jun 1, 2012, 00:00

  • PMS2 The Efficacy of Duloxetine, Non-Steroidal Anti-Inflammatory Drugs, and Opioids in Osteoarthritis- A Meta-Analysis

    Jun 1, 2012, 00:00

  • PMS50 Benefits in Patient Reported Outcomes Supporting a “Treat to Target” Paradigm for Infliximab -Treated RA Patients Previously Inadequately Responsive to Prior Anti-TNF Treatment

    Jun 1, 2012, 00:00

  • PMH53 Measuring Real World Outcomes by Incorporating PRO Data Collection into Patient Access Support Programs

    Jun 1, 2012, 00:00

  • PIN35 Decision Analysis Model Evaluating the Cost-Effectiveness of Fidaxomicin and Vancomycin in the Treatment of Clostridium Difficile Infection (CDI) from a Hospital Perspective

    Jun 1, 2012, 00:00

  • PCV42 Cost Analysis of Venous Thromboembolism Prophylaxis After Total Knee Replacement and Total Hip Replacement

    Jun 1, 2012, 00:00

  • PIN55 Anti-Malarial Drugs Management in Public and Private Secondary Health Care Facilities- A Comparative Cross Sectional Study from Pakistan

    Jun 1, 2012, 00:00

  • PMH57 Cross-Country Comparisons of Adults with Major Depressive Disorder

    Jun 1, 2012, 00:00

  • PHP38 Out-of-Pocket Drug Expenditure Among Users of the Ambulatory Care Services at the Mexican Institute of Social Security (IMSS)

    Jun 1, 2012, 00:00

  • PUK1 the Effect of Coadminstration of Nicotinamide and Calcium-Based Phosphate Binder on Hyperphophatemia in Patients Undergoing Hemodialysis

    Jun 1, 2012, 00:00

  • PRM43 Robustness of Confidence Intervals for Rare Events

    Jun 1, 2012, 00:00

  • PND54 Short and Long-Term Variations in All Cause Health Care Utilization and Costs for Newly Diagnosed Multiple Sclerosis Patients Enrolled in Either Medicaid HMO or Commercial HMO

    Jun 1, 2012, 00:00

  • PDB98 Treatment Patterns and Treatment Restrictions of Patients With Type II Diabetes Receving Care From Home Health Care Agencies, Skilled Nursing Facilities, and Veterans Affairs Settings in the United States

    Jun 1, 2012, 00:00

  • PSY56 Impact of Early Versus Late Systemic Lupus Erythematosus (SLE) Diagnosis on Clinical and Economic Outcomes

    Jun 1, 2012, 00:00

  • PGI8 Prevalence of Gastroprotective Agent Use Among Adults with Arthritis Taking NSAIDS

    Jun 1, 2012, 00:00

  • CE4 A Framework for Stakeholder Engagement in Comparative Effectiveness Research

    Jun 1, 2012, 00:00

  • PHP47 The Economic Impact of a Cost-Effectiveness Threshold on the Innovative Drug Expenditure in Qatar

    Jun 1, 2012, 00:00

  • PMH19 Combination Utilization Patterns and Treatment Predictors in ADHD in a Commercially Insured Population

    Jun 1, 2012, 00:00

  • PSS25 Actinic Keratosis Patients are Willing to Pay for Shorter Treatment and Local Skin Response Duration and Ingenol Mebutate Gel is Likely to Increase Patient Likelihood of Successful Completion of Topical Treatment

    Jun 1, 2012, 00:00

  • PRS1 Assessing the Association of Omalizumab Use and Arteriothrombotic Events Through Spontaneous Adverse Event Reporting

    Jun 1, 2012, 00:00

  • RM3 Antipsychotic Use and Risk of All-Cause Mortality in Elderly Dual Eligible Beneficiaries

    Jun 1, 2012, 00:00

  • PCN16 Design and Rationale of the Multiple Myeloma Preamble Study- A Prospective, Non-Interventional, Multi-Center Cohort Study

    Jun 1, 2012, 00:00

  • PDB59 Cost-Effectiveness Analysis of Medication Therapy Management in Patients with Type 2 Diabetes in Community Pharmacy/Ambulatory Care Settings- Results From a Decision-Analytic Markov Model

    Jun 1, 2012, 00:00

  • PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients with Moderate and Severe Asthma

    Jun 1, 2012, 00:00

  • PMH36 An Economic Evaluation of Screening for Dementia in South Korea

    Jun 1, 2012, 00:00

  • PRM23 Proqolid Database- Where Are We Ten Years After Its Launch?

    Jun 1, 2012, 00:00

  • PSY31 Economic Evaluation of Eletriptan 40mg for Migraine Therapy in Korea

    Jun 1, 2012, 00:00

  • PRS3 Inhaled Anticholinergics and Risk of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease- a Systematic Review and Meta Analysis of Randomized Controlled Trials

    Jun 1, 2012, 00:00

  • PRS5 Co-Morbid Depression and Its Impact on Health Care Expenditure among Individuals with Asthma

    Jun 1, 2012, 00:00

  • PIH77 Annual Overall and Epilepsy-Related Health Care Utilization in Adult Epilepsy Patients in the United States

    Jun 1, 2012, 00:00

  • PCN2 Depression Treatment in Individuals With Physical Illnesses- A Comparison Between Cancer and Cardio-Metabolic Conditions

    Jun 1, 2012, 00:00

  • PND11 Cost of Cervical Dystonia in the United States

    Jun 1, 2012, 00:00

  • PCN61 Cost-Effectiveness of Sunitinib + Best Supportive Care for the Treatment of Unresectable Pancreatic Neuroendocrine Tumors in Mexico

    Jun 1, 2012, 00:00

  • PMH10 Functional Outcome Measures- A Powerful Tool to Demonstrate Treatment Success in Schizophrenia

    Jun 1, 2012, 00:00

  • PCV97 Real World Patient Profile of Patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 Regions of China

    Jun 1, 2012, 00:00

  • PCV43 Economic Burden of Venous Thromboembolism in Orthopedic Surgery Patients in Colombia

    Jun 1, 2012, 00:00

  • PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)

    Jun 1, 2012, 00:00

  • PCN32 Comparing Health Care Resource Use, Costs and Adverse Events Among Lung Cancer Patients Treated With Standard Chemotherapy With or Without an Angiogenesis Inhibitor- A Retrospective Database Study

    Jun 1, 2012, 00:00

  • PRM11 The Rise Of Budget Impact Analyses

    Jun 1, 2012, 00:00

  • PSU16 Retrospective Analysis of Cost Outcomes for Patients Receiving Infuse Bone Graft (rhBMP-2) or Actifuse Bone Graft Substitute (Si-CaP) During Posterolateral Spinal Fusion

    Jun 1, 2012, 00:00

  • CN4 Total Health Care Costs for Colorectal Cancer Patients Following Metastatic Diagnosis

    Jun 1, 2012, 00:00

  • PMD39 Projection of Health Economics Benefits of Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose in Type 1 Diabetes, in Sweden

    Jun 1, 2012, 00:00

  • PIN20 Costs of Probable Bacterial Pneumonia in Children Under 5 Years Old in Colombia

    Jun 1, 2012, 00:00

  • PIN60 Epidemiology of Pneumococcal Diseases in Mexico in Patients Older Than 50 Years Old

    Jun 1, 2012, 00:00

  • PIN12 Cost Analysis of Rilpivirine Versus Efavirenz for Treatment of Human Immunodeficiency Virus (HIV)

    Jun 1, 2012, 00:00

  • PDB55 Estimating the Cost-Effectiveness of Premixed Analog Insulin Versus Long Acting Analog Basal Insulin and Premixed Human Insulin in the Management of Type 2 Diabetes- A Long Term Analysis in the United Kingdom (UK)

    Jun 1, 2012, 00:00

  • PHP78 Development of a New System for Registration of Patient Registries

    Jun 1, 2012, 00:00

  • PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing- Opportunities and Challenges Associated with an Integrated Personalized Medicine Approach

    Jun 1, 2012, 00:00

  • PHP83 Community Health Workers- A Literature Review in Some Countries of South America

    Jun 1, 2012, 00:00

  • PHP30 The Bittersweet Success of Orphan Drugs

    Jun 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118 (current)
  • 119
  • 120
  • »